U.S. Rep. John Joyce (R-PA-13) said in a hearing today that the federal 340b’s growth has created “misaligned incentives” that are driving up patient costs.
A member of the Pennsylvania Board of Pharmacy said a bill sponsored by State Sen. Judy Ward (R-Hollidaysubrg) would create more transparency from pharmacy benefit managers (PBMs) on the drug rebates these PBMs receive from drug manufacturers.